Status:
UNKNOWN
Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
This multinational, non-interventional, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent mitral valve transcatheter edge-to-edge repair (M-TEER) for ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- clinically significant primary mitral regurgitation
- patient underwent M-TEER
- echocardiography data at baseline, procedure and follow-up
- follow-up of at least 12 months
- Exclusion Criteria
- age under 18 years
Exclusion
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05332782
Start Date
March 1 2022
End Date
January 1 2026
Last Update
April 18 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
New York, New York, United States, 10467
2
Centre Hospitalier de Bordeaux
Bordeaux, France
3
Université Lille, Inserm, Centre Hospitalier Universitaire de Lille
Lille, France
4
University Hospital of Rennes, Centre Hospitalier de Rennes
Rennes, France